StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3071% below fair value
$2.91−0.30 (-9.35%)

Close on Nov 16, 2026Market cap $28.95MP/E –Yield –

Scynexis enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Scynexis's enterprise value was -$37.12M on Nov 11, 2026, against -$8.95M a year earlier. Over the last 5 years it ranged from -$45.16M to $45.37M, with a median of -$24.80M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$37.12M–
2025Dec 31, 2025-$11.37M–
2024Dec 31, 2024-$38.99M–
2023Dec 29, 2023-$22.30M–
2022Dec 30, 2022-$45.16M-199.5%
2021Dec 31, 2021$45.37M-14.1%
2020Dec 31, 2020$52.84M+31.1%
2019Dec 31, 2019$40.31M+89.3%
2018Dec 31, 2018$21.29M-70.2%
2017Dec 29, 2017$71.54M+21.0%
2016Dec 30, 2016$59.10M+81.4%
2015Dec 31, 2015$32.59M-36.0%
2014Dec 31, 2014$50.91M–

More Scynexis figures

See a number that looks wrong?